Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2133-2141

  Tamura, Kazutoshi ^a   Nakae, Dai ^a   Horiguchi, Kohsuke ^a   Akai, Hiroyuki ^a   Kobayashi, Yozo ^a   Andoh, Nobuaki ^a   Satoh, Hiroshi ^a   Denda, Ayumi ^a   Tsujiuchi, Toshifumi ^a   Yoshiji, Hitoshi ^b,c   Konishi, Yoichi ^a  

^a National Cancer Center   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; DIETHYLNITROSAMINE; DNA; FAT; FENRETINIDE; GLUTATHIONE TRANSFERASE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DIETARY INTAKE; DNA DAMAGE; FATTY LIVER; LIVER CARCINOGENESIS; LIVER NECROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL HEPATECTOMY; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; BROMODEOXYURIDINE; CHOLINE DEFICIENCY; DEOXYGUANOSINE; FENRETINIDE; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PLACENTA; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TRETINOIN;

EID: 18144436551     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2133     Document Type: Article

References (66)

1. Bollag, W. (1971) Effects of vitamin A acid on transplantable and chemically induced tumors. Cancer Chemother. Rep., 55, 53-58.
2. Smithm, M.A., Parkinson, D.R., Cheson, B.D. and Friedman, M.A. (1992) Retinoids in cancer therapy. J. Clin. Oncol., 10, 839-864.
3. Posch, K., Enright, W. and Napoli, J. (1989) Retinoic acid synthesis by cytosol from the alcohol dehydrogenase negative deermouse. Arch. Biochem. Biophys., 274, 171-178.
4. Chytil, F. (1986) Retinoic acid: biochemistry and metabolism. J. Am. Acad. Dermatol., 15, 741-747.
5. Lacroix, A., Doskas, C. and Bhat, P. (1990) Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovarietomy. Cancer Res., 50, 5731-5734.
6. Muindi, J.R.F., Frankel, S.R., Huselton, C., De Grazia, F., Garland, W.A., Young, C.W. and Warrel, R.P., Jr. (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res., 52, 2138-2142.
7. Adamson, P.C. (1994) Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia. Semin.-Hematol., 31, 14-17.
8. Moon, R.C. Thompson, H.J., Becci, P.J., Shealy, C.J., Gander, R.L., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen, L.T., Brown, C.C. and Sporn, M.B. (1979) N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39, 1339-1346.
9. Dollar, G.R., Hixson, E.J., Arthur, M.W. and Denine, E.P. (1978) Comparative subacute toxicity of N-ethyl retinamide, N-(4-hydroxyethyl)retinamide, and N-(4-hydroxyphenyl)retinamide in mice. Pharmacologist, 20, 248.
10. Rotmensz, N., de Palo, G., Formelli, F., Costa, A., Marubini, E., Campa, T., Crippa, A., Danesini, G.M., Delle Grottaglie, M., di Mauro, M.G., Filiberti, A., Gallazzi, M., Guzzon, A., Magni, A., Malone, W., Mariani, L., Palvarini, M., Perloff, M., Pizzichetta, M. and Veronesi, U. (1991) Long term tolerability of fenretinide (4-HPR) in breast cancer patients. Eur. J. Cancer, 27, 1127-1131.
11. Peng, Y.M., Dalton, W.S., Alberts, D.S., Xu, M., Lim, H. and Meyskens, F.L. (1989) Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int. J. Cancer, 43, 22-26.
12. Hixson, E.J. and Denine, E.P. (1979) Comparative subacute toxicity of retinyl acetate and three synthetic retinamides in Swiss mice. J. Natl Cancer Inst., 63, 1359-1364.
13. Bunk, M.J., Kinahan, J.J. and Sarkar, N.H. (1985) Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Cancer Lett., 26, 319-326.
14. Formelli, F., Carsana, R., Costa, A., Buranelli, F., Campa, T., Dossena, G., Magni, A. and Pizzichetta, M. (1989) Plasma retinol level reduction by the synthetic retinoid Fenretinide: a one year follow-up study of breast cancer patients. Cancer Res., 49, 6149-6152.
15. Moon, R.C. (1989) Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer. J. Nutr., 119, 127-134.
16. Moon, R.C., Mehta, R.G. and Rao, K.V.N. (1994) Retinoids and cancer in experimental animals. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds) The Retinoids: Biology, Chemistry and Medicine, 2nd Edn. Raven Press Ltd, New York, pp. 573-595.
17. Veronesi, U., de Palo, G., Costa, A., Formelli, F., Marubini, E. and del Vecchio, M. (1992) Chemoprevention of breast cancer with retinoids. Monogr. Natl Cancer Inst., 12, 93-97.
18. de Palo, G., Veronesi, U., Marubini, E., Camerini, T., Chiesa, F., Nava, M., Formelli, F., Del Vecchio, M., Costa, A., Boracchi, P. and Mariani, L. (1995) Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia. J. Cell. Biochem., 22 (suppl.), 11-17.
19. Tradati, N., Chiesa, F., Rossi, N., Grigolato, R., Formelli, F., Costa, A. and de Palo, G. (1994) Successful topical treatment of oral lichen planus and leuloplakias with fenretinide (4-HPR). Cancer Lett., 76, 109-111.
20. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P. Mariani, L., Clerici, M., Formelli, F., Barzan, L., Carrassi, A., Pastorini, A., Camerini, T., Giardini, R., Zurrida, S., Minn, F.L., Costa, A., de Palo, G. and Veronesi, U. (1992) Prevention of local relapses and new localizations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Eur. J. Cancer, 28B, 97-102.
21. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Formelli, F., Giardini, R., Costa, A., de Palo, G. and Veronesi, U. (1993) Fenretinide (4-HPR) in chemoprevention of oral leuoplakia. J. Cell. Biochem., 17F (suppl.), 255-261.
22. Mitchell, M.F., Hittelman, W.K., Lotan, R., Nishioka, K., Tortolero-Luna, G., Richards-Konum, R., Wharton, J.T. and Hong, W.K. (1995) Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer, 76 (suppl.), 1956-1977.
23. McCormick, D.L., Hollister, J.L., Bagg, B.J. and Long, R.E. (1990) Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides. Carcinogenesis, 11, 1605-1609.
24. Baba, M., Iishi, H., Yamamoto, R. and Tatsuta, M. (1991) Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene proein in Sprague-Dawley rats. Int. J. Cancer, 49, 467-470.
25. Mack, D.O., Reed, V.L. and Smith, L.D. (1990) Retinyl acetate inhibition of 3′-methyl-4-dimethyl-aminoazobenzene induced hapatic neoplasia. Int. J. Biochem., 22, 359-365.
26. Daoud, A.H. and Griffin, A.C. (1980) Effect of retinoic acid, butylated hydroxytoluene, selenium, and sorbic acid on azo-dye hepatocarcinogenesis. Cancer Lett., 8, 299-304.
27. Moriwaki, H., Muto, Y., Ninomiya, M., Kawai, K., Suzuki, Y. and Seto, T. (1988) Inhibitory effect of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3′-methyl-N,N-dimethyl-4-aminoazobenzene. Gastroenterol. Jpn., 23, 546-552.
28. Pegg, A.E. (1977) Formation and metabolism of alkylated nucleosides: possible role in carcinogenesis by nitroso-compounds and alkylating agents. Adv. Cancer Res., 25, 195-269.
29. Saffhill, R., Margison, G.P. and O'Connor, P.J. (1985) Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta, 823, 111-145.
30. Singer, B. and Crunberger, D. (1984) Molecular Biology and Mutagens and Carcinogens. Plenum Press, New York, NY.
31. Nakae, D., Yoshiji, H., Mizumoto, Y., Horiguchi, K,. Shiraiwa, K., Tamura, K., Denda, A. and Konishi, Y. (1992) High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Cancer Res., 52, 5042-5045.
32. Denda, A., Tang, Q., Endoh, T., Tsujiuchi, T., Horiguchi, K., Noguchi, O., Mizumoto, Y., Nakae, D. and Konishi, Y. (1994) Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L -amino acid-defined diets in rats. Carcinogenesis, 15, 1279-1283.
33. 2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis, 17, 467-475.
34. Tatematsu, M., Mera, Y., Ito, N., Satoh, K. and Sato, K. (1985) Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis, 6, 1621-1626.
35. Hendrich, S., Campbell, H.A. and Potot, H.C. (1987) Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis, 8, 1245-1250.
36. Floyd, R.A. (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis, 11, 1447-1450.
37. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990) Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res., 81, 213-215.
38. Nakae, D., Yoshiji, H., Maruyama, H., Kinugasa, T., Denda, A. and Konishi, Y. (1990) Production of both 8-hydroxydeoxyguanosine in liver DNA and γ-glutamyltransferase-positive hepatocellular lesions in rats given a choline-deficient, L-amino acid-defined diet. Jpn. J. Cancer Res., 81, 1081-1084.
39. Chung, F.-L. and Xu, Y. (1992) Increased 8-oxodeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine, 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone. Carcinogenesis, 13, 1269-1272.
40. Nakae, D., Kobayashi, Y., Akai, H., Andoh, N., Satoh, H., Ohashi, K., Tsutsumi, M. and Konishi, Y. (1997) Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res., 57, 1281-1287.
41. Yoshiji, H., Nakae, D., Mizumoto, Y., Horiguchi, K., Tamura, K., Denda, A., Tsujii, T. and Konishi, Y. (1992) Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet. Carcinogenesis, 13, 1227-1233.
42. Nakae, D., Mizumoto, Y., Yoshiji, H., Andoh, N., Horiguchi, K., Kobayashi, E., Endoh, T., Shimoji, N., Tamura, K., Tsujiuchi, T., Denda, A. and Konishi, Y. (1994) Different roles of 8-hydroxyguanine formation and 2-thiobarbituric acid-reacting substances generation in the early phase of liver carcinogenesis induced by a choline-deficient, L-amino acid-defined diet in rats. Jpn. J. Cancer Res., 85, 499-505.
43. Mizumoto, Y., Nakae, D., Yoshiji, H., Andoh, N., Horiguchi, K., Endoh, T., Kobayashi, E., Tsujiuchi, T., Shimoji, N., Denda, A., Tsujii, T., Nagao, M., Wakabayashi, K. and Konishi, Y. (1994) Inhibitory effects of 2-O-octadecylascorbic acid and other vitamin C and E derivatives on the induction of enzyme-altered putative preneoplastic lesions in the livers of rats fed a choline deficient L-amino acid defined diet. Carcinogenesis, 15, 241-246.
44. McCormick, D.L., Becci, P.J. and Moon, R.C. (1982) Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2). Carcinogenesis, 3, 1473-1477.
45. McCormick, D.L., Mehta, R.G., Thompson, C.A., Dinger, N., Caldwell, J.A. and Moon, R.C. (1982) Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hyroxyphenyl)retinamide and ovariectomy. Cance Res., 42, 508-512.
46. Ito, N., Tatematsu, M., Hasegawa, R. and Tsuda, H. (1989) Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P-positive liver cell focus as an endpoint marker. Toxicol. Pathol., 17, 630-641.
47. Ito, N., Hasegawa, R., Imaida, K., Hirose, M., Shirai, T., Tamano, S. and Hagiwara, A. (1997) Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J. Toxicol. Pathol., 10, 1-11.
48. Higgins, G.M. and Anderson, R.M. (1931) Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. Lab. Med., 12, 1186-1202.
49. Nakae, D., Mizumoto, Y., Kobayashi, E., Noguchi, O. and Konishi, Y. (1995) Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett., 97, 233-239.
50. Kuchino, Y., Mori, F., Kasai, H., Inoue, H., Iwai, S., Miura, K., Ohtsuka, E. and Nishimura, S. (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature, 327, 77-79.
51. Kasai, H., Nishimura, S., Kurokawa, Y. and Hayashi, Y. (1987) Oral administration of renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis, 8, 1959-1961.
52. Nakae, D., Andoh, N., Mizumoto, Y., Endoh, T., Shimoji, N., Horiguchi, K., Shiraiwa, K., Tamura, K., Denda, A. and Konishi, Y. (1994) Selective 8-hydroxyguanine formation in pancreatic DNA due to a single intravenous administration of 4-hydroxyaminoquinoline-1-oxide in rats. Cancer Lett., 83, 97-103.
53. Folch, J.L. (1957) A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509.
54. Spayd, R.W., Bruschi, B., Buridick, B.A., Dappen, G.M., Eikenberry, J.N., Esders, T.W., Figueras, J., Goodhue, C.T., LaRossa, D.D., Nelson, R.W., Rand, R.N. and Wu, T.W. (1978) Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin. Chem., 24, 1343-1350.
55. Bergmeyer, H.U., Scheibe, P. and Wahlefeld, A.W. (1978) Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem., 24, 58-73.
56. Kivirikko, K.I., Lailinen, O. and Prockop, D.J. (1967) Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem., 19, 249-255.
57. Farber, E. (1984) Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture. Cancer Res., 44, 5463-5474.
58. Farber, E. and Sarma, D.S.R. (1987) Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest., 56, 4-22.
59. Dowlatshahi, K., Mehta, R.G., Thomas, C.F., Dinger, N.M. and Moon, R.C. (1989) Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer. Cancer Lett., 47, 187-192.
60. Domenico, D., Antonella, A., Luciano, L., Pier, G.P., Francesco, G., Fausto, G., Franca, F., Sylvie, M., Alberto, C., Umberto, V. and Marco, A.P. (1993) N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hematopoietic cell lines including those unresponsive to retinoic acid. Cancer Res., 53, 6036-6041.
61. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistoia, V., Raffaghello, L., Rozzo, C. and Montaldo, G. (1995) Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cell: apoptosis versus differentiation. Cancer Res., 55, 853-861.
62. Levine, L. (1980) N-(4-hydroxyphenyl)retinamide: a synthetic analog of vitamin A that is a potent inhibitor of prostaglandin biosynthesis. Prostag. Med., 4, 285-296.
63. Fielder-Nagy, C., Hamilton, J.G., Batula-Bernardo, C. and Coffey, J.W. (1983) Inhibition of △-5-lipoxygenase (△-5-LO), △-12-lipoxygenase (△-12-LO), and prostaglandin endoperoxide synthetase (PES) by selected retinoids (vitamin A derivatives). Fed. Proc., 42, 919.
64. Lombardi, B. and Smith, M.L. (1994) Tumorigenesis, protooncogene activation, and other gene abnormalities in methyl deficiency. J. Nutr. Biochem., 5, 2-9.
65. Saito, R., Jahnke-Spinnenweber, E., Shinozuka, H. and Lombardi, B. (1994) On the role of compensatory mitogenesis in the hepatocarcinogenicity of choline and multiple-lipotrope devoid diets. Carcinogenesis, 15, 1413-1419.
66. Keenan, K.P. (1996) The uncontrolled variable in risk assessment: ad libitum overfed rodents - fat, facts and fiction. Toxicol. Pathol., 24, 376-383.